World News: 12:30 GMT Thursday 6th December 2018. [BeyondSpring, Inc. via Globe Newswire via SPi World News]
NEW YORK Dec 06 2018 GLOBE NEWSWIRE -- NASDAQ BYSI a global biopharmaceutical company focused on the development of innovative cancer therapies today announced that the Phase 3 portion of its pivotal Study 105 evaluating its lead asset , Plina...
Globe Newswire: 12:30 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.